167 related articles for article (PubMed ID: 30354114)
1. Nuclear Receptors Database Including Negative Data (NR-DBIND): A Database Dedicated to Nuclear Receptors Binding Data Including Negative Data and Pharmacological Profile.
Réau M; Lagarde N; Zagury JF; Montes M
J Med Chem; 2019 Mar; 62(6):2894-2904. PubMed ID: 30354114
[TBL] [Abstract][Full Text] [Related]
2. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.
Lagarde N; Ben Nasr N; Jérémie A; Guillemain H; Laville V; Labib T; Zagury JF; Montes M
J Med Chem; 2014 Apr; 57(7):3117-25. PubMed ID: 24666037
[TBL] [Abstract][Full Text] [Related]
3. Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches.
Lagarde N; Delahaye S; Jérémie A; Ben Nasr N; Guillemain H; Empereur-Mot C; Laville V; Labib T; Réau M; Langenfeld F; Zagury JF; Montes M
Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28671755
[TBL] [Abstract][Full Text] [Related]
4. Identification of ligand binding pockets on nuclear receptors by machine learning methods.
Oak N; Jayaraman VK
Protein Pept Lett; 2014; 21(8):808-14. PubMed ID: 23855664
[TBL] [Abstract][Full Text] [Related]
5. NURA: A curated dataset of nuclear receptor modulators.
Valsecchi C; Grisoni F; Motta S; Bonati L; Ballabio D
Toxicol Appl Pharmacol; 2020 Nov; 407():115244. PubMed ID: 32961130
[TBL] [Abstract][Full Text] [Related]
6. IUPHAR-DB: updated database content and new features.
Sharman JL; Benson HE; Pawson AJ; Lukito V; Mpamhanga CP; Bombail V; Davenport AP; Peters JA; Spedding M; Harmar AJ;
Nucleic Acids Res; 2013 Jan; 41(Database issue):D1083-8. PubMed ID: 23087376
[TBL] [Abstract][Full Text] [Related]
7. Allosteric small molecule modulators of nuclear receptors.
Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
[TBL] [Abstract][Full Text] [Related]
8. Application of computational approaches to study signalling networks of nuclear and Tyrosine kinase receptors.
Choura M; Rebaï A
Biol Direct; 2010 Oct; 5():58. PubMed ID: 20937105
[TBL] [Abstract][Full Text] [Related]
9. Modulation of nuclear receptor function: Targeting the protein-DNA interface.
Veras Ribeiro Filho H; Tambones IL; Mariano Gonçalves Dias M; Bernardi Videira N; Bruder M; Amorim Amato A; Migliorini Figueira AC
Mol Cell Endocrinol; 2019 Mar; 484():1-14. PubMed ID: 30703486
[TBL] [Abstract][Full Text] [Related]
10. Detection of endocrine and metabolism disrupting xenobiotics in milk-derived fat samples by fluorescent protein-tagged nuclear receptors and live cell imaging.
Thakur K; Goud ESK; Jawa Y; Keswani C; Onteru S; Singh D; Singh SP; Roy P; Tyagi RK
Toxicol Mech Methods; 2023 May; 33(4):293-306. PubMed ID: 36154553
[TBL] [Abstract][Full Text] [Related]
11. Accurate prediction of nuclear receptors with conjoint triad feature.
Wang H; Hu X
BMC Bioinformatics; 2015 Dec; 16():402. PubMed ID: 26630876
[TBL] [Abstract][Full Text] [Related]
12. Noncanonical mechanisms to regulate nuclear receptor signaling.
Sadana P
Future Med Chem; 2012 Jun; 4(10):1307-33. PubMed ID: 22800372
[TBL] [Abstract][Full Text] [Related]
13. Profiling of 3696 Nuclear Receptor-Coregulator Interactions: A Resource for Biological and Clinical Discovery.
Broekema MF; Hollman DAA; Koppen A; van den Ham HJ; Melchers D; Pijnenburg D; Ruijtenbeek R; van Mil SWC; Houtman R; Kalkhoven E
Endocrinology; 2018 Jun; 159(6):2397-2407. PubMed ID: 29718163
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of nuclear receptor-ligand interactions.
Greschik H; Moras D
Curr Top Med Chem; 2003; 3(14):1573-99. PubMed ID: 14683516
[TBL] [Abstract][Full Text] [Related]
15. Ligand Pathways in Nuclear Receptors.
Fischer A; Smieško M
J Chem Inf Model; 2019 Jul; 59(7):3100-3109. PubMed ID: 31246455
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.
Cortés-Cabrera A; Morris GM; Finn PW; Morreale A; Gago F
Br J Pharmacol; 2013 Oct; 170(3):557-67. PubMed ID: 23826885
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areas.
Sladek FM
Expert Opin Ther Targets; 2003 Oct; 7(5):679-84. PubMed ID: 14498828
[TBL] [Abstract][Full Text] [Related]
18. Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation.
Zhou G; Cummings R; Hermes J; Moller DE
Methods; 2001 Sep; 25(1):54-61. PubMed ID: 11558997
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
20. Non-canonical modulators of nuclear receptors.
Tice CM; Zheng YJ
Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
